SG Americas Securities LLC Purchases 89,866 Shares of Globe Life Inc. $GL

SG Americas Securities LLC increased its position in Globe Life Inc. (NYSE:GL) by 909.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 99,746 shares of the company’s stock after buying an additional 89,866 shares during the period. SG Americas Securities LLC owned 0.13% of Globe Life worth $13,950,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. CX Institutional grew its position in Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company’s stock worth $258,000 after acquiring an additional 96 shares in the last quarter. Laird Norton Wetherby Wealth Management LLC raised its holdings in shares of Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares in the last quarter. KLP Kapitalforvaltning AS lifted its stake in shares of Globe Life by 0.5% in the 3rd quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock valued at $3,145,000 after purchasing an additional 100 shares during the last quarter. Clearstead Advisors LLC boosted its holdings in Globe Life by 1.9% in the third quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock worth $754,000 after purchasing an additional 100 shares in the last quarter. Finally, Journey Strategic Wealth LLC boosted its holdings in Globe Life by 5.0% in the third quarter. Journey Strategic Wealth LLC now owns 2,103 shares of the company’s stock worth $301,000 after purchasing an additional 101 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Trading Down 2.5%

Shares of GL stock opened at $135.26 on Friday. The firm has a market capitalization of $10.61 billion, a P/E ratio of 9.61 and a beta of 0.46. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The firm’s fifty day simple moving average is $141.45 and its 200 day simple moving average is $138.84. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business earned $3.14 earnings per share. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 1.0%. Globe Life’s payout ratio is currently 7.67%.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,192,969.04. This trade represents a 25.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 82,807 shares of company stock worth $12,041,286. 1.51% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Evercore set a $157.00 target price on Globe Life in a report on Wednesday, February 18th. Truist Financial upped their price target on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Texas Capital raised Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. TD Cowen restated a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Finally, JPMorgan Chase & Co. upped their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $172.00.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.